We are analyzing https://link.springer.com/article/10.1007/s10456-011-9207-3.

Title:
Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma | Angiogenesis
Description:
Background Vascular endothelial growth factor (VEGF) that is secreted by tumor cells plays a key role in angiogenesis. Matrix metalloproteinase 9 (MMP-9) is produced by inflammatory cells, such as stromal granulocytes (PMN), remodels the extracellular matrix and is known to promote angiogenesis indirectly by interacting with VEGF. The aim of this study was to determine the role of PMN-derived MMP-9, its interaction with VEGF, and the efficacy of anti-angiogenic therapy targeting MMP-9 with oral Doxycycline and VEGF with Bevacizumab in pancreatic cancer (PDAC). Methodology/principal findings Inhibitors to MMP-9 (Doxycycline) and VEGF (Bevacizumab) were used alone or in combination in an in vitro angiogenesis assay to test their effect on angiogenesis caused by MMP-9, VEGF, PMN and PDAC cells. In an in vivo model of xenografted PDAC, treatment effects after 14 days under monotherapy with oral Doxycycline or Bevacizumab and a combination of both were evaluated. In vitro, PMN-derived MMP-9 had a direct and strong proangiogenic effect that was independent and additive to PDAC-derived VEGF. Complete inhibition of angiogenesis required the inhibition of VEGF and MMP-9. In vivo, co-localization of MMP-9, PMN and vasculature was observed. MMP inhibition with oral Doxycycline alone resulted in a significant decrease in PDAC growth and mean vascular density comparable to VEGF inhibition alone. Conclusions/significance PMN derived MMP-9 acts as a potent, direct and VEGF independent angiogenic factor in the context of PDAC. MMP-9 inhibition is as effective as VEGF inhibition. Targeting MMP-9 in addition to VEGF is therefore likely to be important for successful anti-angiogenic treatment in pancreatic cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Social Networks

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, google, scholar, pubmed, cas, cancer, angiogenesis, mmp, vegf, pancreatic, cell, matrix, endothelial, growth, factor, cells, angiogenic, vascular, inhibition, tumor, metalloproteinase, biol, role, therapy, bevacizumab, combination, access, human, clin, privacy, cookies, content, switch, tobias, doxycycline, pdac, hanahan, brown, metalloproteinases, van, gemcitabine, publish, search, derived, independent, pausch, pmn, study, advanced, dvorak,

Topics {✒️}

month download article/chapter carlos fernandez-del-castillo ulrich theodor hopt inhibitor-free enzyme catalyzes de jonge-muller es double-blind placebo-controlled tumour angiogenesis factors fixed-dose rate gemcitabine thomas pausch successful anti-angiogenic treatment advanced renal-cell carcinoma article angiogenesis aims vascular permeability factor full article pdf pancreatic ductal adenocarcinoma line anti-vegf therapy human endothelial cells tumour angiogenesis advanced pancreatic cancer privacy choices/manage cookies pmn-derived mmp-9 unresectable pancreatic cancer metastatic pancreatic cancer infiltrating neutrophils mediate orthotopic pancreatic xenografts human ovarian carcinoma increased microvascular permeability endothelial fenestration induced tumor cell migration tumor cells plays tumor cells secrete vascular density comparable related subjects chemically modified tetracyclines soluble native type phase ii trial tobias keck author information authors promote angiogenesis indirectly low-dose cisplatin golub lm pdac-derived vegf article bausch mmp-independent mechanisms phase iii trial anti-vegf strategy van laethem jl van hinsbergh vw european economic area reactivate angiogenic activity

Questions {❓}

Ko AH, Dito E, Schillinger B, Venook AP, Xu Z, Bergsland EK, Wong D, Scott J, Hwang J, Tempero MA (2008) A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma
         description:Vascular endothelial growth factor (VEGF) that is secreted by tumor cells plays a key role in angiogenesis. Matrix metalloproteinase 9 (MMP-9) is produced by inflammatory cells, such as stromal granulocytes (PMN), remodels the extracellular matrix and is known to promote angiogenesis indirectly by interacting with VEGF. The aim of this study was to determine the role of PMN-derived MMP-9, its interaction with VEGF, and the efficacy of anti-angiogenic therapy targeting MMP-9 with oral Doxycycline and VEGF with Bevacizumab in pancreatic cancer (PDAC). Inhibitors to MMP-9 (Doxycycline) and VEGF (Bevacizumab) were used alone or in combination in an in vitro angiogenesis assay to test their effect on angiogenesis caused by MMP-9, VEGF, PMN and PDAC cells. In an in vivo model of xenografted PDAC, treatment effects after 14 days under monotherapy with oral Doxycycline or Bevacizumab and a combination of both were evaluated. In vitro, PMN-derived MMP-9 had a direct and strong proangiogenic effect that was independent and additive to PDAC-derived VEGF. Complete inhibition of angiogenesis required the inhibition of VEGF and MMP-9. In vivo, co-localization of MMP-9, PMN and vasculature was observed. MMP inhibition with oral Doxycycline alone resulted in a significant decrease in PDAC growth and mean vascular density comparable to VEGF inhibition alone. PMN derived MMP-9 acts as a potent, direct and VEGF independent angiogenic factor in the context of PDAC. MMP-9 inhibition is as effective as VEGF inhibition. Targeting MMP-9 in addition to VEGF is therefore likely to be important for successful anti-angiogenic treatment in pancreatic cancer.
         datePublished:2011-03-26T00:00:00Z
         dateModified:2011-03-26T00:00:00Z
         pageStart:235
         pageEnd:243
         sameAs:https://doi.org/10.1007/s10456-011-9207-3
         keywords:
            VEGF
            MMP-9
            Neutrophil granulocyte
            Pancreatic cancer
            Cancer Research
            Biomedicine
            general
            Cell Biology
            Cardiology
            Ophthalmology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-011-9207-3/MediaObjects/10456_2011_9207_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-011-9207-3/MediaObjects/10456_2011_9207_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-011-9207-3/MediaObjects/10456_2011_9207_Fig3_HTML.gif
         isPartOf:
            name:Angiogenesis
            issn:
               1573-7209
               0969-6970
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Dirk Bausch
               affiliation:
                     name:University of Freiburg
                     address:
                        name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas Pausch
               affiliation:
                     name:Universität Heidelberg
                     address:
                        name:Klinik für Allgemein, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tobias Krauss
               affiliation:
                     name:Radiologische Universitätsklinik Freiburg i. Br.
                     address:
                        name:Radiologische Universitätsklinik Freiburg i. Br., Freiburg i. Br., Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ulrich Theodor Hopt
               affiliation:
                     name:University of Freiburg
                     address:
                        name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carlos Fernandez-del-Castillo
               affiliation:
                     name:Massachusetts General Hospital and Harvard Medical School
                     address:
                        name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrew L. Warshaw
               affiliation:
                     name:Massachusetts General Hospital and Harvard Medical School
                     address:
                        name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sarah P. Thayer
               affiliation:
                     name:Massachusetts General Hospital and Harvard Medical School
                     address:
                        name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tobias Keck
               affiliation:
                     name:University of Freiburg
                     address:
                        name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma
      description:Vascular endothelial growth factor (VEGF) that is secreted by tumor cells plays a key role in angiogenesis. Matrix metalloproteinase 9 (MMP-9) is produced by inflammatory cells, such as stromal granulocytes (PMN), remodels the extracellular matrix and is known to promote angiogenesis indirectly by interacting with VEGF. The aim of this study was to determine the role of PMN-derived MMP-9, its interaction with VEGF, and the efficacy of anti-angiogenic therapy targeting MMP-9 with oral Doxycycline and VEGF with Bevacizumab in pancreatic cancer (PDAC). Inhibitors to MMP-9 (Doxycycline) and VEGF (Bevacizumab) were used alone or in combination in an in vitro angiogenesis assay to test their effect on angiogenesis caused by MMP-9, VEGF, PMN and PDAC cells. In an in vivo model of xenografted PDAC, treatment effects after 14 days under monotherapy with oral Doxycycline or Bevacizumab and a combination of both were evaluated. In vitro, PMN-derived MMP-9 had a direct and strong proangiogenic effect that was independent and additive to PDAC-derived VEGF. Complete inhibition of angiogenesis required the inhibition of VEGF and MMP-9. In vivo, co-localization of MMP-9, PMN and vasculature was observed. MMP inhibition with oral Doxycycline alone resulted in a significant decrease in PDAC growth and mean vascular density comparable to VEGF inhibition alone. PMN derived MMP-9 acts as a potent, direct and VEGF independent angiogenic factor in the context of PDAC. MMP-9 inhibition is as effective as VEGF inhibition. Targeting MMP-9 in addition to VEGF is therefore likely to be important for successful anti-angiogenic treatment in pancreatic cancer.
      datePublished:2011-03-26T00:00:00Z
      dateModified:2011-03-26T00:00:00Z
      pageStart:235
      pageEnd:243
      sameAs:https://doi.org/10.1007/s10456-011-9207-3
      keywords:
         VEGF
         MMP-9
         Neutrophil granulocyte
         Pancreatic cancer
         Cancer Research
         Biomedicine
         general
         Cell Biology
         Cardiology
         Ophthalmology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-011-9207-3/MediaObjects/10456_2011_9207_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-011-9207-3/MediaObjects/10456_2011_9207_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10456-011-9207-3/MediaObjects/10456_2011_9207_Fig3_HTML.gif
      isPartOf:
         name:Angiogenesis
         issn:
            1573-7209
            0969-6970
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Dirk Bausch
            affiliation:
                  name:University of Freiburg
                  address:
                     name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas Pausch
            affiliation:
                  name:Universität Heidelberg
                  address:
                     name:Klinik für Allgemein, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tobias Krauss
            affiliation:
                  name:Radiologische Universitätsklinik Freiburg i. Br.
                  address:
                     name:Radiologische Universitätsklinik Freiburg i. Br., Freiburg i. Br., Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ulrich Theodor Hopt
            affiliation:
                  name:University of Freiburg
                  address:
                     name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carlos Fernandez-del-Castillo
            affiliation:
                  name:Massachusetts General Hospital and Harvard Medical School
                  address:
                     name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrew L. Warshaw
            affiliation:
                  name:Massachusetts General Hospital and Harvard Medical School
                  address:
                     name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sarah P. Thayer
            affiliation:
                  name:Massachusetts General Hospital and Harvard Medical School
                  address:
                     name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tobias Keck
            affiliation:
                  name:University of Freiburg
                  address:
                     name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Angiogenesis
      issn:
         1573-7209
         0969-6970
      volumeNumber:14
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Freiburg
      address:
         name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
         type:PostalAddress
      name:Universität Heidelberg
      address:
         name:Klinik für Allgemein, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:Radiologische Universitätsklinik Freiburg i. Br.
      address:
         name:Radiologische Universitätsklinik Freiburg i. Br., Freiburg i. Br., Germany
         type:PostalAddress
      name:University of Freiburg
      address:
         name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
         type:PostalAddress
      name:Massachusetts General Hospital and Harvard Medical School
      address:
         name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Massachusetts General Hospital and Harvard Medical School
      address:
         name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Massachusetts General Hospital and Harvard Medical School
      address:
         name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
         type:PostalAddress
      name:University of Freiburg
      address:
         name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Dirk Bausch
      affiliation:
            name:University of Freiburg
            address:
               name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
               type:PostalAddress
            type:Organization
      name:Thomas Pausch
      affiliation:
            name:Universität Heidelberg
            address:
               name:Klinik für Allgemein, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Tobias Krauss
      affiliation:
            name:Radiologische Universitätsklinik Freiburg i. Br.
            address:
               name:Radiologische Universitätsklinik Freiburg i. Br., Freiburg i. Br., Germany
               type:PostalAddress
            type:Organization
      name:Ulrich Theodor Hopt
      affiliation:
            name:University of Freiburg
            address:
               name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
               type:PostalAddress
            type:Organization
      name:Carlos Fernandez-del-Castillo
      affiliation:
            name:Massachusetts General Hospital and Harvard Medical School
            address:
               name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Andrew L. Warshaw
      affiliation:
            name:Massachusetts General Hospital and Harvard Medical School
            address:
               name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Sarah P. Thayer
      affiliation:
            name:Massachusetts General Hospital and Harvard Medical School
            address:
               name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Tobias Keck
      affiliation:
            name:University of Freiburg
            address:
               name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
      name:Klinik für Allgemein, Viszeral- und Transplantationschirurgie, Universität Heidelberg, Heidelberg, Germany
      name:Radiologische Universitätsklinik Freiburg i. Br., Freiburg i. Br., Germany
      name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
      name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
      name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
      name:Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
      name:Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(165)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.58s.

LINK . SPRINGER . COM {}